Skip to Content

RSN 35 mg (Risedronate sodium 35 mg)

Pill imprint RSN 35 mg has been identified as Risedronate sodium 35 mg.

Risedronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substance Act (CSA).

Risedronate sodium 35 mg RSN 35 mg
Risedronate sodium 35 mg RSN 35 mg Front
Risedronate sodium 35 mg RSN 35 mg Back
Discount Card Promo
Risedronate sodium
RSN 35 mg
35 mg
Elliptical / Oval
Prescription only
Drug Class:
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Actavis Pharma, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.